Product Images Adalimumab
View Photos of Packaging, Labels & Appearance
- Figure 1. Study RA-III ACR 20 Responses over 52 Weeks - image 01
- Figure 2. ASAS 20 Response By Visit, Study AS-I - image 02
- Hulio Pen Logo - image 03
- Pen Instructions for Use Figure A - image 04
- Pen Instructions for Use Figure B - image 05
- Pen Instructions for Use Figure C - image 06
- Pen Instructions for Use Figure D - image 07
- Pen Instructions for Use Figure E - image 08
- Pen Instructions for Use Figure F - image 09
- Pen Instructions for Use Figure G - image 10
- Pen Instructions for Use Figure H - image 11
- Pen Instructions for Use Figure I - image 12
- Pen Instructions for Use Figure J - image 13
- Hulio Syringe Logo - image 14
- Instructions for Use Figure A - image 15
- Instructions for Use Figure B - image 16
- Instructions for Use Figure C - image 17
- Instructions for Use Figure D - image 18
- Instructions for Use Figure E - image 19
- Instructions for Use Figure F - image 20
- Instructions for Use Figure G - image 21
- Instructions for Use Figure H - image 22
- Instructions for Use Figure I - image 23
- Adalimumab-fkjp Prefilled Syringe Carton - 20 mg/0.4 mL - image 24
- Adalimumab-fkjp Prefilled Syringe Carton - 40 mg/0.8 mL - image 25
- Adalimumab-fkjp Prefilled Pen - 40 mg/0.8 mL - image 26
- Figure 3: Kaplan-Meier Curves Summarizing Time to Treatment Failure on or after Week 6 (Study UV I) or Week 2 (Study UV II) - image 27
Product Label Images
The following 27 images provide visual information about the product associated with Adalimumab NDC 83257-022 by Biocon Biologics Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1. Study RA-III ACR 20 Responses over 52 Weeks - image 01
Figure 2. ASAS 20 Response By Visit, Study AS-I - image 02
Hulio Pen Logo - image 03
Pen Instructions for Use Figure A - image 04
This text provides instructions for an Adalimumab Pen Injection. It mentions an Orange Indicator inside the barrel, a caution for the Orange Activator with a needle inside, and guidance not to uncap until you are ready to inject and won't be interrupted. It also includes details like the Fill Marker, Small Inner Gray Cap, and Protective Clear Cap.*
Pen Instructions for Use Figure B - image 05
Pen Instructions for Use Figure C - image 06
This text appears to contain information about a figure labeled "CE", a fill marker for medicine, and the presence of bubbles being normal.*
Pen Instructions for Use Figure D - image 07
Pen Instructions for Use Figure E - image 08
Pen Instructions for Use Figure F - image 09
This is a "Squeeze Site" that can be used for evaluating the abdomen or thighs. This site may refer to a location where a person is instructed to squeeze or pinch for assessment purposes.*
Pen Instructions for Use Figure G - image 10
Pen Instructions for Use Figure H - image 11
Pen Instructions for Use Figure I - image 12
Pen Instructions for Use Figure J - image 13
Hulio Syringe Logo - image 14
Instructions for Use Figure A - image 15
This is a description of a medicine fill marker with instructions on when to uncap the needle cap and a needle safety feature that activates after the syringe is used. The text also mentions that the strength and expiration date shown may vary.*
Instructions for Use Figure B - image 16
Instructions for Use Figure C - image 17
This text appears to be discussing a fill marker used in medicine, mentioning the presence of bubbles as a normal occurrence.*
Instructions for Use Figure D - image 18
Instructions for Use Figure E - image 19
Instructions for Use Figure F - image 20
This description refers to a product or service related to websites focusing on managing weight, fitness, or wellness. It could be about exercises, diet plans, or products targeting the abdomen or thighs for toning or weight loss.*
Instructions for Use Figure G - image 21
Instructions for Use Figure H - image 22
Instructions for Use Figure I - image 23
Adalimumab-fkjp Prefilled Syringe Carton - 20 mg/0.4 mL - image 24
Adalimumab-fkjp Prefilled Syringe Carton - 40 mg/0.8 mL - image 25
Adalimumab-fkjp Prefilled Pen - 40 mg/0.8 mL - image 26
This appears to be information related to a medication known as Adalimumab-fkjp Pen Injection, with the concentration of 40 mg/0.8 mL. The text provides details on subcutaneous use, storage instructions, composition of the solution, and specific handling guidance. It emphasizes using the pen within a certain timeframe after removal from the refrigerator and gives additional storage instructions for room temperature. The text contains directions for administration and crucial details to note, such as not using the medication beyond its expiration date. The product should be stored with protection from light and not frozen. Additionally, it mentions the importance of following the instructions on the pen label after removal from the refrigerator.*
Figure 3: Kaplan-Meier Curves Summarizing Time to Treatment Failure on or after Week 6 (Study UV I) or Week 2 (Study UV II) - image 27
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
